Greater Occipital and Supraorbital Nerve Blockade in Migraine Patients

Greater Occipital and Supraorbital Nerve Blockade For The Preventive Treatment of Migraine

The investigators aimed to evaluate the efficacy of greater occipital nerve and supraorbital nerve blockade with local anesthetics for the preventive treatment of migraine without aura.

A mixture of 1 ml 2% lidocaine and 0.9% 1 ml saline was injected bilaterally to GON and SON in the blockade patients. Placebo patients received 2 ml 0.9% saline in the same way. Patients were blinded to kind of injection.

Inclusion Criteria:

• Lack of benefits 1 year from preventive treatment or intolerance to their treatments.
• 18 ≥ years old
• Migraine without aura for more than 1 year, minimum of two or more migraine attacks per month.

Exclusion Criteria:

• Patients with any chronic illness, medication overuse headache, a history of cranial and cervical surgery
• Allergies to local anesthetics
• Hemorrhagic diathesis
• Alcohol or drug abuse